Kyowa Kirin Co (STU:KY4) Accounts Payable: €674 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:KY4 Kyowa Kirin Co Ltd STU:KY4
87 GF Score
Price €12.40
GF Value €15.04
Valuation Modestly Undervalued
View Full Analysis

What is Kyowa Kirin Co Accounts Payable?

Kyowa Kirin Co STU:KY4 -2.36% 87 Accounts Payable is €674 Mil as of Jun. 2026. GuruFocus rates STU:KY4 with a GF Score™ of 87/100 and a GF Value™ of €15.04 (Modestly Undervalued).

Kyowa Kirin Co's Accounts Payable for the quarter that ended in Jun. 2026 was €674 Mil.

Kyowa Kirin Co's quarterly Accounts Payable declined from Dec. 2025 (€679 Mil) to Mar. 2026 (€587 Mil) but then increased from Mar. 2026 (€587 Mil) to Jun. 2026 (€674 Mil).

Kyowa Kirin Co's annual Accounts Payable declined from Dec. 2023 (€78 Mil) to Dec. 2024 (€78 Mil) and declined from Dec. 2024 (€78 Mil) to Dec. 2025 (€42 Mil).

Kyowa Kirin Co Accounts Payable Related Terms

Kyowa Kirin Co Accounts Payable Historical Data

* Premium members only.

The historical data trend for Kyowa Kirin Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kyowa Kirin Co Accounts Payable Chart

Kyowa Kirin Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 106.08 67.36 78.04 77.66 42.08

Kyowa Kirin Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 641.28 712.96 679.24 586.93 674.27
STU:KY4
87GF Score
Kyowa Kirin Co Ltd STU:KY4
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kyowa Kirin Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of €674 Mil mean?
Kyowa Kirin Co (STU:KY4) has a Accounts Payable of €674 Mil as of Jun. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Kyowa Kirin Co and its competitors.
Is Kyowa Kirin Co's Accounts Payable too high?
Kyowa Kirin Co's current Accounts Payable is €674 Mil. Overall, Kyowa Kirin Co has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kyowa Kirin Co's Accounts Payable compare to ZTS?
Kyowa Kirin Co's Accounts Payable of €674 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Kyowa Kirin Co and its competitors. Kyowa Kirin Co's current Accounts Payable is €674 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kyowa Kirin Co stock overvalued right now?
Based on GuruFocus' analysis, Kyowa Kirin Co (STU:KY4) is currently considered Modestly Undervalued. The stock's GF Value™ is €15.04, compared to a current price of €12.40 — trading 17.6% below its estimated fair value. The current Accounts Payable is €674 Mil. Kyowa Kirin Co's overall GF Score™ is 87/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Kyowa Kirin Co (STU:KY4), the current Accounts Payable is €674 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kyowa Kirin Co (STU:KY4) Overvalued in 2026?

Based on GuruFocus' analysis, Kyowa Kirin Co stock appears to be undervalued. The current stock price of €12.40 is trading 17.6% below its estimated GF Value™ of €15.04. GuruFocus considers Kyowa Kirin Co to be Modestly Undervalued.

Key valuation signals for STU:KY4:

  • Accounts Payable: €674 Mil
  • GF Value™: €15.04 vs. price of €12.40 (17.6% below fair value)
  • GF Score™: 87/100

No single metric tells the full story. See the STU:KY4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kyowa Kirin Co Business Description

Address 1-9-2 Otemachi, Chiyoda-ku, Chiyoda-ku, Tokyo, JPN, 100-0004
Kyowa Kirin Co Ltd is engaged in research, development, manufacturing, sales, import and export of prescription pharmaceuticals. Its products include KHK4083/AMG 451, rocatinlimab; ziftomenib; OTL-203 KK8398, infigratinib; KHK4951, tivozanib; OTL-201; KK4277; KK2260; KK2269; KK2845; and KK8123.
87GF Score

Get the complete analysis for STU:KY4

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.40
Price
€15.04
GF Value